Article
Medicare Payment for Calcium Modification Technologies Among Patients Undergoing Percutaneous Coronary Intervention, 2021-2022
2025-01-13
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Background</h4> The Centers for Medicare and Medicaid Services (CMS) New Technology Add-on Payment (NTAP) program supports adoption of new, costly medical technologies demonstrating substantial clinical improvement. In 2021, CMS waived the “substantial clinical improvement” criterion for devices designated under the FDA Breakthrough Devices Program (BDP). This study characterized risk-standar...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c8073849-694f-5765-9f2f-6971e4a27ee4
- DOI
- 10.1101/2025.01.12.25320423
